Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

MDVN Insider Trading

MDVN | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at MDVN provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2009-03-19 23:08 2009-03-18 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $16.66 20,000 $333,276 396,123 -4.8%
2009-01-24 02:40 2009-01-22 Bailey Gregory Director SELL $19.04 22,000 $418,770 228,508 -8.8%
2008-12-06 01:25 2008-12-03 Seely Lynn Officer - Chief Medical Officer OPT+S $14.16 9,000 $127,409 0 0.0%
2008-12-06 01:24 2008-12-03 Hung David Director, Officer - President and CEO SELL $13.90 25,000 $347,435 1,449,641 -1.7%
2008-12-06 01:23 2008-12-03 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $14.21 10,000 $142,121 416,123 -2.3%
2008-10-07 23:32 2008-10-03 HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD. 10% owner, Other SELL $23.08 415,657 $9,594,278 911,088 -31.3%
2008-10-04 00:26 2008-10-01 HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD. 10% owner, Other SELL $24.84 179,000 $4,446,038 1,050,055 -14.6%
2008-10-02 01:03 2008-09-29 HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD. 10% owner, Other SELL $26.66 317,672 $8,468,754 1,109,722 -22.3%
2008-09-29 20:00 2008-09-25 Seely Lynn Officer - Chief Medical Officer OPT+S $29.57 9,000 $266,117 0 0.0%
2008-09-29 20:00 2008-09-25 Hung David Director, Officer - President and CEO SELL $29.69 25,000 $742,248 1,474,641 -1.7%
2008-09-29 19:59 2008-09-25 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $29.64 10,000 $296,394 426,123 -2.3%
2008-09-18 23:39 2008-09-17 Bailey Gregory Director SELL $29.70 22,000 $653,404 250,508 -8.1%
2008-09-12 02:03 2008-09-11 BLICKENSTAFF KIM D Director OPT+S $33.05 20,000 $661,046 0 0.0%
2008-09-10 20:42 2008-08-29 Protter Andrew A Officer - VP, Preclinical Development OPT+S $29.57 24,000 $709,579 0 0.0%
2008-09-06 00:14 2008-09-03 HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD. 10% owner, Other BUY $29.94 500,000 $14,970,000 1,219,666 +69.5%
2008-08-06 00:18 2008-08-01 HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD. 10% owner, Other BUY $20.01 84,000 $1,680,840 2,120,667 +4.1%
2008-07-23 00:08 2008-07-18 Bailey Gregory Director SELL $19.00 22,000 $418,000 272,508 -7.5%
2008-06-17 20:24 2006-10-30 VERNON W ANTHONY Director BUY $11.87 4,266 $50,652 4,266 +100.0%
2008-06-12 01:02 2008-06-09 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $14.90 10,000 $149,036 436,123 -2.2%
2008-06-12 01:01 2008-06-09 Seely Lynn Officer - Chief Medical Officer OPT+S $14.94 9,000 $134,426 0 0.0%
2008-06-12 01:00 2008-06-09 Hung David Director, Officer - President and CEO SELL $14.89 25,000 $372,248 1,499,641 -1.6%
2008-03-14 23:45 2008-03-12 Adams Daniel Director SELL $13.65 10,190 $139,126 0 -100.0%
2008-03-06 01:00 2008-03-03 Hung David Director, Officer - President and CEO SELL $15.64 25,000 $391,003 1,524,641 -1.6%
2008-03-06 01:00 2008-03-03 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $15.63 10,000 $156,252 446,123 -2.2%
2008-03-05 23:49 2008-03-03 Seely Lynn Officer - Chief Medical Officer OPT+S $15.64 9,000 $140,721 0 0.0%
2007-12-06 03:43 2007-12-03 Hung David Director, Officer - President and CEO SELL $13.14 25,000 $328,475 1,549,651 -1.6%
2007-12-06 03:42 2007-12-03 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $13.10 10,000 $131,033 456,123 -2.1%
2007-12-06 03:42 2007-12-03 Seely Lynn Officer - Chief Medical Officer OPT+S $13.11 9,000 $117,954 0 0.0%
2007-10-12 23:13 2007-10-11 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $24.31 13,229 $321,616 2,689,664 -0.5%
2007-09-22 00:51 2007-09-19 Hung David Director, Officer - President and CEO SELL $19.01 25,000 $475,288 1,574,651 -1.6%
2007-09-22 00:51 2007-09-19 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $18.92 10,000 $189,210 466,123 -2.1%
2007-09-22 00:51 2007-09-19 Seely Lynn Officer - Chief Medical Officer OPT+S $18.94 9,000 $170,460 0 0.0%
2007-06-08 01:09 2007-06-05 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $16.67 10,000 $166,724 476,123 -2.1%
2007-06-08 01:08 2007-06-05 Seely Lynn Officer - Chief Medical Officer OPT+S $16.70 9,000 $150,291 0 0.0%
2007-06-08 01:08 2007-06-05 Hung David Director, Officer - President and CEO SELL $16.42 25,000 $410,583 1,599,651 -1.5%
2007-05-16 19:09 2007-05-14 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $18.99 28,700 $544,910 2,702,893 -1.1%
2007-04-24 16:54 2007-04-20 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $20.00 58,700 $1,174,076 2,731,593 -2.1%
2007-03-21 01:07 2007-03-16 Machado Clarence Patrick Officer - Sr. Vice President and CFO SELL $17.80 10,000 $178,000 486,123 -2.0%
2007-03-21 01:06 2007-03-16 Hung David Director, Officer - President and CEO SELL $17.80 25,000 $445,000 1,624,651 -1.5%
2007-03-21 01:06 2007-03-16 Adams Daniel Director OPT+S $17.80 10,190 $181,382 0 0.0%
2007-03-21 01:06 2007-03-16 Seely Lynn Officer - Chief Medical Officer OPT+S $17.80 9,000 $160,200 0 0.0%
2007-02-12 20:09 2007-02-08 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $17.70 25,000 $442,500 2,800,793 -0.9%
2007-02-09 00:23 2007-02-06 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $16.47 81,000 $1,334,418 2,825,793 -2.8%
2007-02-06 22:45 2007-02-02 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $15.22 26,400 $401,856 2,906,793 -0.9%
2007-02-03 00:51 2007-02-01 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $15.00 200 $3,000 2,933,193 0.0%
2006-10-13 22:34 2006-10-12 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner BUY $13.37 6,000 $80,241 2,933,393 +0.2%
2006-10-13 22:34 2006-10-11 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $13.92 7,000 $97,433 2,927,393 -0.2%
2006-08-10 17:46 2006-08-08 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $4.40 131,600 $579,040 3,075,293 -4.1%
2006-03-03 22:08 2006-03-01 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $4.99 10,325 $51,523 3,206,893 -0.3%
2006-03-01 23:55 2006-02-27 MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner SELL $4.59 38,900 $178,718 3,217,218 -1.2%
SHOW ENTRIES

How to Interpret $MDVN Trades

Not every insider transaction in MDVN is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MDVN shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for MDVN

Insider activity data for MDVN is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MDVN, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.